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the activity of the MyHC IIx promoter in C2C12 mouse myoblasts and primary rabbit skeletal myotubes (23) . As the main contractile element of muscle fibers, MyHC isoforms are frequently used as markers of fiber type, but they are not the only molecules that determine the muscle phenotype. MyHC is responsible for muscle contraction, and the sarcoplasmic/endoplasmic reticulum Ca 2ϩ ATPase (SERCA) isoforms are responsible for relaxation (1) . SERCA isoforms are normally expressed in coordination with the corresponding MyHC isoforms in the fibers of skeletal muscle. The isoform SERCA1 is expressed exclusively in fast skeletal muscle of adults, while the SERCA2a isoform is expressed in slow skeletal muscle of adults (1) .
Cn is a protein phosphatase that is activated by Ca 2ϩ -calmodulin, and it dephosphorylates nuclear factor of activated T cells (NFAT) transcription factors. The dephosphorylation of NFAT proteins causes their translocation from the cytoplasm to the nucleus, where they bind to enhancer elements of specific genes leading to transcriptional activation (9) . Among these, four distinct genes encoding closely related NFAT proteins (NFATc1-c4) have been identified. Knockout of NFATc1 is embryonically lethal due to defects in cardiogenesis (3), whereas knockout of either NFATc2 or NFATc3 results in muscle atrophy (12, 16) . The upregulation of MyHC I gene expression is thought to involve NFATc1 during the fast-to-slow fiber type shifts in rodent skeletal muscle cells (33) . Mice with targeted NFATc4 disruption exhibit no known phenotype (7) . Thus the four NFAT isoforms probably have distinctive roles in fiber type determination within skeletal muscle.
Peroxisome proliferator-activated receptor-␥ coactivator (PGC)-1␣ is a key modulator of the mitochondrial network and one of the factors that regulate muscle fiber type determination (19) . It interacts with nuclear respiratory factor-1 (NRF-1), which increases the expression of mitochondrial transcription factor A (mtTFA) and several nuclear genes that encode respiratory chain components and mtTFA induces the expression of mitochondrial genes that encode subunits of the electron transport chain complex, such as ␤-ATP synthase, cytochrome c, and cytochrome c oxidase I (COX I; Ref. 6 ). The transgenic expression of PGC-1␣ in fast-twitch glycolytic muscles promotes mitochondrial biogenesis and oxidative metabolism and induces type IIb muscle fibers to shift towards a more oxidative phenotype (19) . Exercise induces PGC-1␣ gene expression in human and rodent skeletal muscles (5, 31) .
Regular exercise stimulates mitochondrial biogenesis and increases muscle oxidative capacity (11, 34) . Supplementation with NaHCO 3 enhances athletic performance (10, 22, 28, 32) and improves mitochondrial mass and respiration in the rat soleus muscle (2) . Because athletic performance is closely associated with the balance of muscle fiber types and mitochondrial function, we hypothesized that fiber type switching is affected by NaHCO 3 supplementation via specific NFAT isoforms. We previously reported that continuous mild heat stress (CMHS) imposed by incubation at 39°C induces a fast-to-slow fiber type shift in mammalian myoblasts (38) . Therefore, the present study aimed to determine whether NaHCO 3 supplementation and CMHS have additive or synergistic effects on fast-to-slow fiber type shifts. We also determined the effects of NaHCO 3 supplementation and CMHS on the expression of molecules associated with mitochondria.
MATERIALS AND METHODS
Cell culture. We used commercially available human skeletal muscle myoblasts (HSMMs) of normal human quadriceps muscle obtained from five Caucasian males, 16, 22, 24, 25 , and 26 yr of age (CC-2580; Lonza, Walkersville, MD). HSMMs were cultured in culture dishes using the SkGM-2 BulletKit according to the manufacturer's protocol (CC-3245; Lonza). The differentiation medium (DM) was DMEM/F-12 (GIBCO, Grand Island, NY) with 2% horse serum, 15 mM HEPES buffer, and 0.25 g/ml fungizone. Media were changed every other day.
NaHCO 3 supplementation and heat stress exposure. HSMMs were seeded in growth medium and incubated at 37°C until they reached 60 -70% confluency. The medium was then changed to DM to induce myotube formation. To determine the effect of varying concentrations of NaHCO 3, the DM was supplemented with 11, 22, 33, or 44 mM NaHCO3 (GIBCO). To determine the effects of CMHS, the cells were cultured at 37 or 39°C in water-jacketed incubators with humidified air mixed with 5% CO2. During the experiments, the culture temperature was monitored continuously using a thermometer with a precision of Ϯ 0.1°C.
RNA interference. FlexiTube small interfering RNAs (siRNAs) for NFATc1 (Hs_NFATC1_7 and Hs_NFATC1_8), NFATc2 (Hs_NFATC2_2 and Hs_NFATC2_5), NFATc3 (Hs_NFATC3_3 and Hs_NFATC3_5), and NFATc4 (Hs_NFATC4_4 and Hs_NFATC4_7) were purchased from Qiagen (Hilden, Germany). Allstars Negative Control siRNA (Qiagen) was used as a negative control. HSMMs at 50% confluence on 48-well plates were transfected with 5 pmol of NFATC siRNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. For each targeted gene we selected two sequences with high silencing efficiency. All experiments were performed with both sequences. After transfection, the medium was changed to DM containing 14 mM NaHCO 3 at 37°C, which is the standard concentration in DM according to the manufacturer's protocol for HSMMs. Cells were harvested after 72 h.
Overexpression experiments. Transient transfections of expression vectors were performed using Lipofectamine 2000 according to the manufacturer's instructions. A total of 2.5 ϫ 10 4 cells/well was transfected with 0.5 g of HaloTag control vector, or HaloTag expression vector carrying NFATc2 (pFN21AB0454, FHC11780) or NFATc4 (pFN21AB0442, FHC03802) (Promega, Madison, WI) on a 24-well plate. Lipofectamine 2000 was used at an amount of 1.0 l/well. After transfection, the medium was changed to DM containing 14 mM NaHCO 3. Cells were harvested after 72 h.
pH measurement. All pH measurements were performed using an Accumet AR10 pH meter (Fisher Scientific, Pittsburgh, PA) in an incubator (5% CO 2) at 37°C.
Western blot analysis. Western blot was carried out with the following primary antibodies: PGC-1␣ (1:1,000, ST1202; Calbiochem, San Diego, CA), MyHC I (1:4,000, clone NOQ7.5.4D; Sigma-Aldrich, St. Louis, MO), MyHC II (1:500, clone MY-32; SigmaAldrich), and ␤-actin (1:1,000, clone AC-15; Sigma-Aldrich). Cells were washed twice with PBS and then lysed with 2ϫ Laemmli sample buffer. Protein concentrations were quantified using the BCA protein assay kit (Thermo Fisher Scientific, Rockford, IL) with BSA as the standard. Aliquots containing 10 g of total protein were separated using 8 -12% SDS-PAGE and electrophoretically transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA). The membrane was then blocked using Tris-buffered saline with 0.05% Tween 20 (TBST) containing 3% skim milk for 1 h and incubated with an appropriately diluted primary antibody in TBST at 4°C overnight. After incubation, membranes were washed three times in TBST and incubated for 1 h with a horseradish peroxidase-labeled secondary antibody (1:5,000, sc-2030 or sc-2031; Santa Cruz Biotechnology, Santa Cruz, CA). The immunoreactive bands were visualized on X-ray films (Fuji Photo Film, Tokyo, Japan) using an Immobilon Western Detection Reagent (Millipore, Billerica, MA).
Quantitative real-time RT-PCR analysis. Total RNA from HSMMs was isolated using the PureLink RNA Mini kit (Invitrogen). After DNase treatment, cDNAs were obtained by reverse transcription of 2 g of total RNA (Sensiscript RT kit; Qiagen). Quantitative real-time RT-PCR (qPCR) was performed using the SYBR Premix Ex Taq (Perfect Real Time) Premix (TaKaRa Bio, Otsu, Japan) or the LightCycler FastStart DNA Master SYBR Green I kit (Roche, Mannheim, Germany) in a fluorescent temperature cycler (LightCycler; Roche). Primer sequences were obtained from previous publications (6, 15, 35, 38) (Table 1 ). The qPCR protocol included initial denaturation at 95°C for 10 min (LightCycler FastStart) or 10 s (SYBR Premix), followed by 40 -50 PCR cycles of 95°C for 5 s and 60°C for 20 s (SYBR Premix), or 95°C for 10 s, 60°C for 10 s, and 72°C for 12 s (LightCycler FastStart). SYBR green fluorescence emissions were determined after each cycle, and the amount of cDNA was quantified using the LightCycler software version 3.5 (Roche). All PCR analyses were performed in triplicate. The housekeeping gene ␤-actin was used as a control template for normalizing relative change of each mRNA in qPCR. The normalized expression level was compared with the control sample.
Fluorescent staining. For immunofluorescent staining, cells were incubated in culture dishes containing collagen type I-coated cover glasses (25 mm type; Iwaki, Tokyo, Japan). At appropriate times, the cells were washed with warm PBS at 37°C and fixed by incubation at room temperature in FME (4% formaldehyde, 2 mM MgCl 2, and 5 mM EGTA in PBS) for 10 min. Cells were washed three times with PBS and permeabilized with FME containing 0.3% Triton X-100 for 10 min at room temperature. The cells were then washed three times with PBS and incubated in PBS containing 1% BSA, 0.02% sodium azide, and an appropriately diluted primary antibody for MyHC (type I, clone NOQ7.5.4D; type II, clone MY-32), NFATc1-c4 (1:100; c1, 7A6, sc-7294; c2, G1-D10, sc-7295; c3, F-1, sc-8405; c4, H-74, sc-13036; Santa Cruz Biotechnology) or COX I (1:200, OxPhos Complex IV Subunit I, clone 1D6E1A8; Invitrogen) at 4°C overnight. The cells were washed three times with PBS, and then reacted for 1 h with fluorescence-conjugated secondary antibody Alexa fluor 488 or 555 (1:500; A11029 or A21424; Invitrogen). To stain functioning mitochondria in living cells, we used MitoTracker Red CMXRos (PA-3017; Lonza) according to the manufacturer's protocol; this stain yields a fluorescent signal the intensity of which is dependent on mitochondrial membrane potential (29). The cover glasses were then rinsed with PBS and mounted with DAPI (VectorShield, H-1500; Vector Laboratories, Burlingame, CA). All photographs were viewed on an Olympus BX51 microscope and were recorded with a digital camera (DP70; Olympus, Tokyo, Japan).
Measurement of fusion index. The fusion index was defined as the ratio of the number of DAPI stained nuclei in myotubes with three or more nuclei to the total number of DAPI stained nuclei in each field. This percentage was determined by counting 1,000 nuclei per dish on 3 independent cultures for each condition.
Intracellular calcium level measurements. HSMMs were loaded with fura-2 AM (5 M, F-1225; Invitrogen) in modified Hanks' solution for 45 min at 37°C. They were then washed three times with modified Hanks' solution, incubated in that solution for 20 min at 37°C, and kept in modified Hanks' solution during analysis. The cells were viewed on an inverted fluorescence microscope (IX71; Olympus) equipped with an on-stage incubation chamber (INUG2-ONICS; Tokai Hit, Shizuoka, Japan) that kept the cells at either 37°C or 39°C under a 5% CO 2 atmosphere. The excitation wavelengths of fura-2 AM are 340 and 380 nm, while the emission wavelength is 510 nm. An intensified CCD camera (ORCA-R2; Hamamatsu Photonics, Shizuoka, Japan) was used for imaging. Image intensities were recorded every second to give a ratio of emitted intensities at excitation wavelengths of 340 and 380 nm, F340/F380. Intracellular calcium level ([Ca 2ϩ ]i) was determined from the F340/F380 ratio. For each experiment, the fluorescence signals of 10 cells were averaged for analysis.
Statistical analysis. The effect of temperature on peak/baseline [Ca 2ϩ ]i was determined using an unpaired Student's t-test. The fusion index and the effects of a single incubation with NaHCO3, siRNA, or NFATc isoform overexpression on MyHC expression were deter- C: Western blot analysis of indicated protein in HSMMs cultured for 7 days in DM containing 11 mM NaHCO3 and indicated concentrations of NaOH using a specific antibody for MyHC I (clone NOQ7.5.4D) or MyHC II (clone MY32). ␤-Actin was used as a loading control. ATPase 1 (SERCA1) and SERCA2a mRNA in HSMMs cultured in DM for 5 days under indicated conditions. Expression levels were determined by qPCR and normalized to ␤-actin expression. Each column shows the means Ϯ SE of 5 independent experiments per treatment. Statistical analyses involved two-way ANOVA and Bonferroni post hoc test. *P Ͻ 0.05 refers to comparisons to cells cultured with 11 mM NaHCO3 at respective temperatures; ## P Ͻ 0.01, main effect of temperature (37 vs. 39°C). D: HSMMs were cultured for 24 or 48 h in DM under indicated conditions. The fusion index of each culture was examined. Each column shows the means Ϯ SE of 3 independent experiments per treatment. Statistical analyses involved one-way ANOVA and Dunnett's post hoc test at the respective times. *P Ͻ 0.05 and **P Ͻ 0.01 refer to comparisons to cells cultured with 11 mM NaHCO3 at 37°C at the respective times. mined using a one-way ANOVA followed by Dunnett's test. The effects of both NaHCO 3 and CMHS on gene expression were analyzed using a two-way ANOVA followed by Bonferroni's post hoc test. Statistical significance was set at P Ͻ 0.05 (GraphPad Prism Statistical Software version 5; GraphPad Software, San Diego, CA).
RESULTS

NaHCO 3 alters expression levels of MyHC isoforms in
HSMMs. To investigate the direct effects of NaHCO 3 on the expression of MyHC isoforms in HSMMs, we incubated HSMMs at 37°C in DM supplemented with 11, 22, 33, or 44 mM NaHCO 3 . Expression of MyHC I or MyHC II isoforms was analyzed by qPCR after 5 days of differentiation. Levels of MyHC I mRNA were significantly higher in the cells cultured with 33 or 44 mM NaHCO 3 than in the control cells cultured in DM containing 11 mM NaHCO 3 ; in contrast, levels of MyHC IIx mRNA were significantly lower in the cells cultured with 33 or 44 mM NaHCO 3 than in the control cells. Expression levels of MyHC IIa were not significantly affected by differences in NaHCO 3 concentrations (Fig. 1A) . We next studied the effects of differences in extracellular pH on shifts in MyHC isoforms. The pH of the DM containing 11 mM NaHCO 3 was 7.4 and that of DM with 44 mM NaHCO 3 was 8.1. To regulate the pH within that range without using NaHCO 3 , we added NaOH or sodium citrate at varying concentrations to DM that contained 11 mM NaHCO 3 (Fig. 1B) . Differentiation of HSMMs was induced for 7 days, and the protein levels of MyHC I and MyHC II were determined by Western blot analysis. In this experiment, the MyHC I protein levels were modestly affected by changes in NaOH concentration, while those of MyHC II decreased only when the cells were cultured in media containing 8 mM NaOH (Fig. 1C) . Similarly, sodium citrate had no significant effects on MyHC switching (data not shown).
CMHS enhances NaHCO 3 -induced changes in MyHC isoform expression and in the fusion process in HSMMs. To test whether the NaHCO 3 -induced fast-to-slow shift of MyHC isoforms was enhanced by CMHS, we incubated the cells in DM supplemented with 11, 22, or 33 mM NaHCO 3 at 37°C or 39°C. We examined the expression of each MyHC isoform at the mRNA level. The levels of MyHC I mRNA were significantly higher at 33 mM NaHCO 3 at 39°C (33 mM/39°C) than at 11 mM/39°C, while those of MyHC IIx were unaffected by CMHS or an increase in the NaHCO 3 concentration (Fig. 2A) .
Changes in levels of MyHC I and IIa were the main effect of CMHS. For fluorescent immunostaining, HSMMs were incubated in DM for 7 days at 11 mM/37°C, 33 mM/37°C, or 33 mM/39°C. Representative images are shown in Fig. 2B . For myotubes expressing MyHC I, the strongest in staining was evident when cells were cultured at 33 mM/39°C; the next strongest staining was observed in myotubes cultured at 33 mM/37°C, and the weakest staining was in myotubes at 11 mM/37°C. In contrast, different culture conditions had little effect on the staining intensity of the myotubes expressing MyHC II.
To further examine the changes in gene expression in myotubes, we assessed the mRNA levels of SERCA1 and SERCA2a in HSMM-derived myotubes after 5 days of differentiation. Levels of SERCA2a mRNA were significantly higher in myotubes that had differentiated at 33 mM/37°C than in those that had differentiated at 11 mM/37°C; in contrast, SERCA1 expression was unaffected by the increase in NaHCO 3 concentration or by CMHS (Fig. 2C) . Differences in SERCA2a expression were the main effect of CMHS.
To investigate the effects of NaHCO 3 and heat stress on the fusion of HSMMs in cultures, we incubated the cells for 24 or 48 h in DM at 11 mM/37°C, 33 mM/37°C, or 33 mM/39°C and measured the fusion index of HSMM cultures. The fusion index was highest at 33 mM/39°C, next highest at 33 mM/37°C, and lowest at 11 mM/37°C at both 24 h and 48 h (Fig. 2D) .
NaHCO 3 and CMHS alter the expression of mitochondriarelated genes in HSMMs.
To address whether NaHCO 3 and CMHS affect the expression of mitochondria-related genes, we examined the expression of PGC-1␣ and of three downstream targets of PGC-1␣-NRF-1, mtTFA, and COX I. Levels of PGC-1␣ transcripts were significantly higher in the cells cultured at 33 mM/37°C or at 33 mM/39°C than in cells cultured at 11 mM/37°C or at 11 mM/39°C, respectively. Differences in PGC-1␣ mRNA expression were the main effect of CMHS. Levels of PGC-1␣ protein were higher at higher NaHCO 3 concentrations, and this trend was more obvious in the cells cultured at 39°C than in those cultured at 37°C (Fig. 3A) . Levels of COX I mRNA were significantly higher in the cells cultured at 33 mM/39°C than in the cells cultured at 11 mM/39°C. Levels of mtTFA mRNA or COX I mRNA were higher in cells cultured at 39°C than in those cultured at 37°C, but levels of NRF-1 mRNA tended to increase only with increasing NaHCO 3 concentrations (Fig. 3B) . To further examine the levels of COX I protein and the mitochondrial membrane potential, HSMMs were maintained in DM under conditions of 11 mM/37°C, 33 mM/37°C, or 33 mM/39°C and then stained with the anti-COX I antibody or MitoTracker Red CMXRos. Figure 3C shows in HSMMs. In this experiment, we added NaHCO 3 to the media and studied the changes in [Ca 2ϩ ] i . Supplementation with NaHCO 3 (11 mM) resulted in an immediate increase in [Ca 2ϩ ] i , which was more obvious in cells cultured at 39°C than in those cultured at 37°C (Fig. 4A, left) ] i at 39°C (1.25 Ϯ 0.01) was significantly greater than that at 37°C (1.07 Ϯ 0.02; Fig. 4A, right) .
To examine the role of Cn in the fiber type shift and PGC-1␣ expression, we compared Cn activity in HSMMs cultured under the different culture conditions. We examined the expression of myocyte-enriched calcineurin-interacting protein 1 (MCIP1) mRNA to estimate Cn activity (6, 39) . The expression of MCIP1 mRNA was significantly higher in the cells cultured at 33 mM/37°C or 33 mM/39°C than in the cells cultured at 11 mM/37°C or 11 mM/39°C, respectively (Fig.  4B) . Differences in MCIP1 mRNA expression were the main effect of CMHS. To further examine the role of Cn, we treated the cells with each of two specific Cn inhibitors, cyclosporine A (Calbiochem) or FK506 (Cayman Chemical, Ann Arbor, MI). HSMMs were incubated in DM containing either 0.25-0.5 M cyclosporine A or 0.5-1.0 M FK506 for 7 days. These Cn inhibitors attenuated the levels of MyHC I and PGC-1␣ proteins but not of MyHC II protein (Fig. 4C) .
Roles of NFAT isoforms in fiber type determination. To investigate the combined effect of NaHCO 3 and CMHS on the expression of NFAT isoforms, we assessed the expression of NFAT mRNAs in HSMMs cultured under several different conditions. Figure 5A shows that all four NFAT isoforms were expressed at substantial levels in HSMMs. At either 37 or 39°C, the levels of NFATc2 and of NFATc4 mRNA were significantly higher in the cells cultured with 33 mM NaHCO 3 than in control cells cultured with 11 mM NaHCO 3 . Changes in levels of NFATc2 and NFATc4 were the main effect of CMHS. In contrast, levels of NFATc1 and NFATc3 mRNA did not differ significantly among the cells cultured under different conditions. To confirm these findings at the protein level, we conducted immunofluorescent staining of the cells. For this, HSMMs were incubated for 7 days in DM at 11 mM/37°C, 33 mM/37°C, or 33 mM/39°C. The cells were stained with antibodies against individual NFAT isoforms for analysis of immunofluorescence. Of the three culture conditions, the fluorescence intensities of NFATc2 and NFATc4 were the most intense in the cells cultured at 33 mM/39°C and next most intense in those cultured at 33 mM/37°C. Fluorescence was least intense in the cells cultured at 11 mM/37°C (Fig. 5B) . In contrast, the fluorescence intensities of NFATc1 or of NFATc3 differed only modestly among cell cultures under these three conditions.
To elucidate the roles of individual NFAT isoforms as potential regulators of MyHC isoforms in HSMMs, we treated the cells with siRNA to knockdown the levels of individual NFAT isoforms and examined the expression of MyHC isoforms. The specificity and efficiency of knockdown of each NFAT isoform was confirmed by qPCR (Fig. 6A) . NFATc2 siRNAs or NFATc4 siRNAs reduced the mRNA levels of MyHC I but not those of MyHC IIx or MyHC IIa. siRNAmediated knockdown of NFATc1 or NFATc3 did not alter the mRNA levels of any of the MyHC isoforms (Fig. 6B) . Figure  6C shows representative immunostaining for individual NFATc isoforms of HSMMs after 72 h of transfection with siRNA. MyHC I staining intensity was obviously reduced by knockdown of NFATc2 or NFATc4 but only marginally by knockdown of NFATc1 or NFATc3. The knockdown of any NFAT isoform did not significantly affect the MyHC II signal.
To further investigate the role of NFATc2 and NFATc4 in MyHC isoforms regulation in HSMMs, we examined the effects of NFATc2 or NFATc4 overexpression on MyHC isoform expression in HSMMs (Fig. 6, D and E) . Western blot analysis showed that the levels of MyHC I protein were significantly higher in cells that overexpressed NFATc2 or NFATc4 than in cells that did not. Moreover, the levels of MyHC II protein did not differ between cells regardless of whether they overexpressed NFATc2 or NFATc4.
DISCUSSION
Athletic performance often improves after ingesting NaHCO 3 (10, 22, 28, 32) . Changes in the expression of MyHC and SERCA isoforms indicated that NaHCO 3 supplementation dose dependently induced fast-to-slow fiber type shifts in HSMMs, which supports our hypothesis. The NaHCO 3 -induced shift in myofiber type was enhanced by CMHS. This effect was additive, because the effects of NaHCO 3 and CMHS did not significantly interact in any analysis (data not shown). We previously reported that CMHS can induce a fast-to-slow shift in fiber type (38) . The present study shows that increased NaHCO 3 concentrations also induce a fast-to-slow shift in MyHC isoform expression in HSMMs. Changes in expression of MyHC I, MyHC IIa, or MyHC IIx that were cause by the suppression of NFATc expression were analyzed by qPCR. mRNA levels were normalized to ␤-actin expression, and the results are presented as relative ratios; cells treated with control siRNA were used as the references for calculating the relative ratios. Each column represents means Ϯ SE of 5 independent experiments per treatment. Statistical analyses involved one-way ANOVA and Dunnett's post hoc test. *P Ͻ 0.05 refers to comparisons to cells given control siRNA (B). C: HSMMs were transfected with control siRNA or siRNAs targeting NFATc1-c4, and cultured in the above-described media for 72 h. The presence of MyHC I or MyHC II was studied by immunofluorescence staining using specific antibodies (scale bar ϭ 100 m). D and E: HSMMs were transfected with an empty control vector or an expression vector carrying NFATc2 or NFATc4, and cultured in DM containing 14 mM NaHCO3. After 72 h, RNA was extracted from cells, and mRNA levels of NFATc2 or NFATc4 were analyzed by qPCR for confirmation of overexpression. Results of qPCR analysis are presented as relative ratios to ␤-actin expression (D). Other cells were harvested at the same time and subjected to Western blot analysis to detect MyHC I or MyHC II. Protein levels were normalized to ␤-actin levels, and the results are presented as relative ratios; cells carrying control vector were used as the reference when calculating the relative ratios (E). Each column represents means Ϯ SE of 5 independent experiments per treatment. Statistical analyses involved one-way ANOVA and Dunnett's post hoc test. *P Ͻ 0.05 refers to comparisons to cells carrying control vector.
Calcium signaling is involved in the determination of muscle fiber type. Kubis et al. (18) reported that a modest but sustained rise in [Ca 2ϩ ] i caused by low concentrations of Ca 2ϩ ionophore A-23187 induced a fast-to-slow fiber type shift in rabbit primary skeletal muscle cells, and Cn has been implicated in a fast-to-slow fiber type shift (25, 33) . The expression of MCIP1 is rapidly and robustly regulated by Cn and thus is recognized as a highly accurate marker of Cn activity (6, 39) . Here, we showed that [Ca 2ϩ ] i and MCIP1 expression was increased by NaHCO 3 supplementation and that these increases were augmented by CMHS. Furthermore, Cn inhibitors caused a slowto-fast shift in MyHC expression. These results are consistent with the notion that changes in calcium signaling are a pivotal mechanism behind the fast-to-slow fiber type shift caused by NaHCO 3 supplementation or CMHS.
Each of the four NFAT isoforms plays a distinctive role in the development of skeletal muscle in rodents. NFATc3 activity is critical for the generation of primary myofibers (16), whereas NFATc2 regulates skeletal muscle growth (12) . NFATc2-null and NFATc3-null mice have an essentially normal composition of muscle fiber types (12, 16) . Somatic gene transfer into adult skeletal muscle of a constitutively active form of NFATc1 enhances the promoter activity of MyHC I and inhibits that of MyHC IIb. Conversely, the expression of MyHC IIa and MyHC IIx is inhibited by siRNAs that target NFATc2, c3, or c4, whereas the fast-glycolytic MyHC-IIb is only inhibited by siRNAs that target NFATc4 (33) . Together, these findings indicate that NFATc2, c3, and c4 are all transcriptionally active in rat fast-type skeletal muscles. Consistent with these findings in vivo, increased [Ca 2ϩ ] i in mouse skeletal myoblasts induces the recruitment of p300 to NFATc1, which increases NFATc1 transcriptional activity and enhances MyHC I expression (23) . Here, we confirmed that all four NFATc isoforms were expressed at substantial levels in these primary cultures of human skeletal muscle. We then found that changes in NFATc2 and NFATc4 levels were involved in the regulation of MyHC I in HSMMs. Although NFATc1 is a regulator of MyHC I gene expression during the fast-to-slow fiber type shift in rodent skeletal muscle cells (33) , the results of our RNA interference experiment indicated that NFATc1 is not involved in the fast-to-slow shift in HSMMs. The activities of NFAT proteins are regulated not only by expression levels but also by their subcellular localization and phosphorylation. Thus further studies are required to clarify the details of the involvement of NFAT proteins in the regulation of MyHC isoforms in HSMMs.
Mitochondrial function depends on the coordinated expression of the mitochondrial and nuclear genomes. PGC-1␣ and the transcription factors NRF-1 and mtTFA that are downstream of PGC-1␣ play important roles in the coordinated expression of these two genomes. These three proteins are therefore considered to be key regulators of mitochondrial biogenesis (5, 6) . Our results showed that NaHCO 3 supplementation increased PGC-1␣ mRNA and protein levels and increased the mitochondrial membrane potential. Moreover, NaHCO 3 -induced changes were augmented by CMHS. Several pathways have been implicated in the signaling that acts upstream of PGC-1␣ transcription, such as the Cn and CaMK, p38 MAPK, Sirtuin 1, and AMP-activated protein kinase pathways (5, 26) . In addition, endurance exercise readily induces PGC-1␣ expression in skeletal muscle in humans (31) . Here, we showed that Cn inhibitors attenuated PGC-1␣ protein levels. However, the protein levels of PGC-1␣ and staining for mitochondrial membrane potential were essentially unaltered by the siRNA-mediated knockdown of individual NFAT isoforms (data not shown), implying that Cn, but not NFAT, is involved in mitochondrial biogenesis and function in human skeletal muscle.
The present study found that NaHCO 3 enhanced and CMHS additively enhanced MCIP1 expression and HSMM fusion. The activation of Cn is linked to the induction of myogenic differentiation that leads to myoblast fusion via myogenin and myocyte enhancer factor-2 (17). We previously reported that CMHS enhances myogenin expression and HSMMs fusion, leading to a fast-to-slow shift in fiber type (38) . Myogenin is implicated in the fast-to-slow fiber-type shift (4, 14) and in a shift of enzyme activity from glycolytic to oxidative metabolism in the skeletal muscles of transgenic mice (14) . NaHCO 3 might affect a fast-toslow fiber-type shift and the expression of molecules associated with mitochondria, leading the differentiation rate of HSMMs through a pathway involving Cn and myogenin.
Accumulating evidence suggests that NaHCO 3 ingestion improves performance during single bouts of anaerobic exercise, repeated short-duration sprints, single-effort prolonged sprints, and prolonged, intermittent exercise at high intensity (10, 22, 28, 32) . McNaughton and Thompson (21) described differences in performance during short-duration, high-intensity cycling between acute and chronic NaHCO 3 loading in humans. Chronic NaHCO 3 ingestion for 6 days allowed participants to perform more work (21) and 0.3 g of NaHCO 3 per kg of body weight are the apparent accepted dose (32) . Thus the dose and duration of NaHCO 3 ingestion might be important factors when attempting to improve athletic performance. We showed that NaHCO 3 supplementation dose dependently enhanced the expression of mitochondrial-related genes and the mitochondrial membrane potential in HSMMs. Bishop et al. (2) reported that oral NaHCO 3 administration before each bout of exercise for 5 wk resulted in improved mitochondrial mass and mitochondrial respiration in the rat soleus muscle. Our findings are consistent with these results. We showed that changes in mitochondrial-related genes and mitochondrial membrane potential do not depend on changes in extracellular pH caused by NaOH or sodium citrate (data not shown). Our findings indicated that NaHCO 3 affects myocyte differentiation via a mechanism other than changes in pH. Therefore, enhanced performance of prolonged exercise after NaHCO 3 ingestion might be associated with changes in mitochondrial mass and function following NaHCO 3 ingestion. Ingestion of NaHCO 3 is thought to enhance performance by increasing extracellular buffering capacity via reducing H ϩ accumulation (2, 32). We speculate that reducing H ϩ accumulation following NaHCO 3 ingestion might lead to short-term improvements in exercise performance. However, additional studies are needed to clarify the mechanism that links NaHCO 3 to improvements in athletic performance.
Mitochondrial dysfunction is implicated in many age-related diseases, such as sarcopenia, insulin resistance and type 2 diabetes (13, 20, 37) . Regular exercise elicits a rapid increase in oxidative enzyme activities, mitochondrial density, and mitochondrial respiration (11, 34) . Prolonged bouts of exercise induce PGC-1␣ gene expression in human skeletal muscle (31) , and exercise conditioning enhances this induction. Muscle temperatures range from 36 to 39.5°C during aerobic exercise such as soccer and cycling (24, 27) ; therefore, a mild increase in muscle temperature may enhance mitochondria-related gene expression. We showed here that NaHCO 3 and CMHS additively induce a fast-to-slow fiber type shift and the expression of mitochondrial-related genes. Thus the present findings might help to establish novel therapeutic strategies to prevent metabolic diseases through improving mitochondrial function.
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